Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inhibikase Therapeutics (IKT)
NASDAQ:IKT
RESEARCH TOOLSreports
Inhibikase Therapeutics (IKT) Financial Statements
102 Followers
Inhibikase Therapeutics Financial Overview
| Mar 24 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | $ 79.57K | $ 116.41K | $ 64.52K | $ 63.57K |
| Gross Profit | - | $ 79.57K | $ 116.41K | $ 64.52K | $ 63.57K |
| EBIT | $ -4.79M | $ -4.77M | $ -6.37M | $ -4.65M | $ -4.26M |
| EBITDA | $ -4.78M | $ -4.76M | $ -6.21M | $ -4.65M | $ -4.25M |
| Net Income Common Stockholders | $ -4.65M | $ -4.60M | $ -5.95M | $ -4.42M | $ -4.20M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 9.75M | $ 16.83M | $ 20.94M | $ 25.72M | $ 23.05M |
| Total Assets | $ 11.07M | $ 17.88M | $ 22.35M | $ 27.93M | $ 24.94M |
| Total Debt | $ 209.49K | $ 270.04K | $ 297.94K | $ 325.01K | $ 351.29K |
| Net Debt | $ -9.54M | $ -16.56M | $ -20.64M | $ -25.39M | $ -22.70M |
| Total Liabilities | $ 4.29M | $ 2.86M | $ 2.88M | $ 2.84M | $ 3.90M |
| Stockholders Equity | $ 6.78M | $ 15.02M | $ 19.46M | $ 25.32M | $ 21.04M |
| Cash Flow | - | ||||
| Free Cash Flow | $ -3.87M | $ -4.11M | $ -4.58M | $ -5.97M | $ -3.56M |
| Operating Cash Flow | $ -3.87M | $ -4.11M | $ -4.57M | $ -5.97M | $ -3.56M |
| Investing Cash Flow | $ -3.31M | $ 17.06M | $ 2.55M | $ -5.84M | $ 4.96M |
| Financing Cash Flow | $ 367.00K | $ 70.00 | $ -35.99K | $ 8.58M | - |